Sanctuary Advisors, LLC Galectin Therapeutics Inc Transaction History
Sanctuary Advisors, LLC
- $15.8 Trillion
- Q4 2024
A detailed history of Sanctuary Advisors, LLC transactions in Galectin Therapeutics Inc stock. As of the latest transaction made, Sanctuary Advisors, LLC holds 58,413 shares of GALT stock, worth $76,521. This represents 0.0% of its overall portfolio holdings.
Number of Shares
58,413
Previous 79,113
26.17%
Holding current value
$76,521
Previous $220 Million
66.8%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding GALT
# of Institutions
98Shares Held
9.82MCall Options Held
1.16MPut Options Held
3.28M-
Vanguard Group Inc Valley Forge, PA2.14MShares$2.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.56MShares$2.05 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ1.18MShares$1.55 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA871KShares$1.14 Million0.0% of portfolio
-
Wealthspire Advisors, LLC New York, NY398KShares$521,8690.0% of portfolio
About GALECTIN THERAPEUTICS INC
- Ticker GALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,426,000
- Market Cap $77.8M
- Description
- Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...